These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38864216)

  • 1. Therapeutic Inhibition of
    Wang Y; Zhang M; Wang R; Lin J; Ma Q; Guo H; Huang H; Liang Z; Cao Y; Zhang X; Lu YW; Liu J; Xiao F; Yan H; Dimitrova N; Huang ZP; Mably JD; Pu WT; Wang DZ
    Circ Res; 2024 Jul; 135(3):434-449. PubMed ID: 38864216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long Noncoding RNA
    Yu J; Yang Y; Xu Z; Lan C; Chen C; Li C; Chen Z; Yu C; Xia X; Liao Q; Jose PA; Zeng C; Wu G
    Circ Heart Fail; 2020 Jan; 13(1):e006525. PubMed ID: 31957467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the Hypoxia-Inducible Factor 1α-Induced Cardiospecific HERNA1 Enhance-Templated RNA Protects From Heart Disease.
    Mirtschink P; Bischof C; Pham MD; Sharma R; Khadayate S; Rossi G; Fankhauser N; Traub S; Sossalla S; Hagag E; Berthonneche C; Sarre A; Stehr SN; Grote P; Pedrazzini T; Dimmeler S; Krek W; Krishnan J
    Circulation; 2019 Jun; 139(24):2778-2792. PubMed ID: 30922078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress.
    Huang ZP; Chen J; Seok HY; Zhang Z; Kataoka M; Hu X; Wang DZ
    Circ Res; 2013 Apr; 112(9):1234-43. PubMed ID: 23524588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The scaffold protein muscle A-kinase anchoring protein β orchestrates cardiac myocyte hypertrophic signaling required for the development of heart failure.
    Kritzer MD; Li J; Passariello CL; Gayanilo M; Thakur H; Dayan J; Dodge-Kafka K; Kapiloff MS
    Circ Heart Fail; 2014 Jul; 7(4):663-72. PubMed ID: 24812305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. lncRNA ZNF593-AS inhibits cardiac hypertrophy and myocardial remodeling by upregulating Mfn2 expression.
    Nie X; Fan J; Wang Y; Xie R; Chen C; Li H; Wang DW
    Front Med; 2024 Jun; 18(3):484-498. PubMed ID: 38743133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MG53, A Novel Regulator of KChIP2 and I
    Liu W; Wang G; Zhang C; Ding W; Cheng W; Luo Y; Wei C; Liu J
    Circulation; 2019 Apr; 139(18):2142-2156. PubMed ID: 30760025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiomyocyte-enriched protein CIP protects against pathophysiological stresses and regulates cardiac homeostasis.
    Huang ZP; Kataoka M; Chen J; Wu G; Ding J; Nie M; Lin Z; Liu J; Hu X; Ma L; Zhou B; Wakimoto H; Zeng C; Kyselovic J; Deng ZL; Seidman CE; Seidman JG; Pu WT; Wang DZ
    J Clin Invest; 2015 Nov; 125(11):4122-34. PubMed ID: 26436652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting muscle-enriched long non-coding RNA H19 reverses pathological cardiac hypertrophy.
    Viereck J; Bührke A; Foinquinos A; Chatterjee S; Kleeberger JA; Xiao K; Janssen-Peters H; Batkai S; Ramanujam D; Kraft T; Cebotari S; Gueler F; Beyer AM; Schmitz J; Bräsen JH; Schmitto JD; Gyöngyösi M; Löser A; Hirt MN; Eschenhagen T; Engelhardt S; Bär C; Thum T
    Eur Heart J; 2020 Sep; 41(36):3462-3474. PubMed ID: 32657324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA Chast promotes cardiac remodeling.
    Viereck J; Kumarswamy R; Foinquinos A; Xiao K; Avramopoulos P; Kunz M; Dittrich M; Maetzig T; Zimmer K; Remke J; Just A; Fendrich J; Scherf K; Bolesani E; Schambach A; Weidemann F; Zweigerdt R; de Windt LJ; Engelhardt S; Dandekar T; Batkai S; Thum T
    Sci Transl Med; 2016 Feb; 8(326):326ra22. PubMed ID: 26888430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489.
    Wang K; Liu F; Zhou LY; Long B; Yuan SM; Wang Y; Liu CY; Sun T; Zhang XJ; Li PF
    Circ Res; 2014 Apr; 114(9):1377-88. PubMed ID: 24557880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling of hypertrophic cardiomyocytes identifies new players in pathological remodelling.
    Vigil-Garcia M; Demkes CJ; Eding JEC; Versteeg D; de Ruiter H; Perini I; Kooijman L; Gladka MM; Asselbergs FW; Vink A; Harakalova M; Bossu A; van Veen TAB; Boogerd CJ; van Rooij E
    Cardiovasc Res; 2021 May; 117(6):1532-1545. PubMed ID: 32717063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pressure overload inhibits glucocorticoid receptor transcriptional activity in cardiomyocytes and promotes pathological cardiac hypertrophy.
    Matsuhashi T; Endo J; Katsumata Y; Yamamoto T; Shimizu N; Yoshikawa N; Kataoka M; Isobe S; Moriyama H; Goto S; Fukuda K; Tanaka H; Sano M
    J Mol Cell Cardiol; 2019 May; 130():122-130. PubMed ID: 30946837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel role of mitochondrial GTPases 1 in pathological cardiac hypertrophy.
    Xu D; Zhao Y; Weng X; Lu Y; Li W; Tang K; Chen W; Liu Z; Qi X; Zheng J; Fassett J; Zhang Y; Xu Y
    J Mol Cell Cardiol; 2019 Mar; 128():105-116. PubMed ID: 30707992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. lncExACT1 and DCHS2 Regulate Physiological and Pathological Cardiac Growth.
    Li H; Trager LE; Liu X; Hastings MH; Xiao C; Guerra J; To S; Li G; Yeri A; Rodosthenous R; Silverman MG; Das S; Ambardekar AV; Bristow MR; González-Rosa JM; Rosenzweig A
    Circulation; 2022 Apr; 145(16):1218-1233. PubMed ID: 35114812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between NFκB and NFAT coordinates cardiac hypertrophy and pathological remodeling.
    Liu Q; Chen Y; Auger-Messier M; Molkentin JD
    Circ Res; 2012 Apr; 110(8):1077-86. PubMed ID: 22403241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Role of Cyclic Nucleotide Phosphodiesterase 10A in Pathological Cardiac Remodeling and Dysfunction.
    Chen S; Zhang Y; Lighthouse JK; Mickelsen DM; Wu J; Yao P; Small EM; Yan C
    Circulation; 2020 Jan; 141(3):217-233. PubMed ID: 31801360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA DCRT Protects Against Dilated Cardiomyopathy by Preventing NDUFS2 Alternative Splicing by Binding to PTBP1.
    Du H; Zhao Y; Wen J; Dai B; Hu G; Zhou Y; Yin Z; Ding N; Li H; Fan J; Nie X; Wang F; Liu Q; Wen Z; Xu G; Wang DW; Chen C
    Circulation; 2024 Sep; 150(13):1030-1049. PubMed ID: 38841852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.
    Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM
    Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SENP1 Protects Against Pressure Overload-Induced Cardiac Remodeling and Dysfunction Via Inhibiting STAT3 Signaling.
    Yang D; Fan D; Guo Z; Liu FY; Wang MY; An P; Yang Z; Tang QZ
    J Am Heart Assoc; 2022 Nov; 11(22):e027004. PubMed ID: 36370010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.